Deborah Kilpatrick, PhD is the Co-CEO and Executive Chair of digital health company Evidation Health in CA. Evidation is a new kind of health and measurement company that provides the world’s most innovative healthcare companies with technology to understand how everyday behavior and health interact. Earlier in her career, she held multiple leadership roles in R&D, new technology development, and New Ventures at Guidant Corporation prior to its acquisition by Boston Scientific (NYSE: BSX), followed by commercial roles at genomic medicine company CardioDx. She currently sits on the college of engineering advisory boards for the Georgia Institute of Technology and the California Polytechnic State University. Deborah is a Director for Sleep Number (NASDAQ: SNBR), a Fellow of the American Institute of Medical and Biological Engineering, and the co-founder of the MedtechVision Conference now held annually in Silicon Valley. She has been named to FierceMedicalDevice’s Top Women in Medtech, FierceBiotech’s Top Women in Biotech, and Silicon Valley Business Journal’s 100 Women of Influence. She holds B.S., M.S. and Ph.D. degrees in engineering from Georgia Tech.
- Experts explore the state of M&A in medtechJanuary 15, 2019
- Prioritizing Innovation – How major players in medtech stay ahead of the curveJanuary 2, 2019
- What should the Mann Foundation do next?December 31, 2018
- Experts explore the state of M&A in medtech
Connect to Us